|
|
Training African Pathologists in Cancer Diagnosis
|
1R13CA232439-01
|
$38,120
|
|
WILSON, MICHAEL
|
AFRICAN STRATEGIES /ADVANCING PATHOLOGY
|
|
|
Womens Interagency HIV Study (WIHS-V)
|
3U01AI035004-25S1
|
$144,370
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Building Research Capacity to Address the Challenge of Non Communicable Diseases and Injuries in Rwanda The GUKORANA Research Center
|
5P20CA210284-02
|
$247,982
|
|
CASTLE, PHILIP
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats
|
5R01CA182284-05
|
$346,525
|
$346,525
|
COLE, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Core Support for Cancer Center
|
5P30CA013330-45
|
$3,646,138
|
$72,923
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Methylome characterization of bronchial epithelial projenitor cells
|
5R21CA209436-02
|
$180,130
|
|
SPIVACK, SIMON
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Assay Development for NSD1 Methyltransferase Inhibitor Discovery
|
5R01CA191077-03
|
$312,244
|
$312,244
|
KOLB, EDWARD
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
|
Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues
|
1R43CA236097-01
|
$300,000
|
|
LIM, MARK
|
AMBERGEN, INC
|
|
|
Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity
|
1R33CA217702-01A1
|
$364,966
|
|
BORGES, CHAD
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Proteasome inhibitors for the treatment of solid tumors
|
5R01CA213223-02
|
$356,014
|
|
KISSELEV, ALEXEI
|
AUBURN UNIVERSITY AT AUBURN
|
|
|
Role of heat shock factors (Hsfs) in tumorigenesis
|
5R01CA132640-16
|
$270,000
|
$135,000
|
MIVECHI, NAHID
|
AUGUSTA UNIVERSITY
|
|
|
P53-dependent immunogenic DCs in the tumor microenvironment
|
1R50CA232983-01
|
$203,853
|
|
SHARMA, MADHAV
|
AUGUSTA UNIVERSITY
|
|
|
DT-EGF Toxic Fusion Protein for the Treatment of Bladder Cancer
|
1R44CA232963-01
|
$299,937
|
|
GLODE, MIKE
|
AURORA ONCOLOGY, INC.
|
|
|
A CD47-blocking oncolytic vaccinia virus for cancer therapy
|
5F30CA203270-03
|
$44,524
|
|
CAO, FELICIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
ALTERED MICROBIOME IN PANCREATITIS, DIABETES AND PANCREATIC CANCER
|
5U01DK108326-04
|
$190,000
|
|
FISHER, WILLIAM
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
|
5R01CA164024-05
|
$319,474
|
$319,474
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
The role of DNMT3A in gene regulation and stem cell expansion
|
5F99CA222736-02
|
$44,524
|
|
HUANG, YUNG-HSIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Context-Specific Functional Annotation of EGFR Mutations in Glioblastoma
|
5F32CA221015-02
|
$59,038
|
|
KONG, KATHLEEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Mechanisms of KLF4 suppression in pediatric leukemia
|
1R01CA207086-01A1
|
$326,540
|
$326,540
|
LACORAZZA, DANIEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Minority PDX Development and Trial Center: Baylor College of Medicine and MD Anderson Cancer Center Collaboration on Mechanistic Studies to Dissect and Combat Health Disparities in Cancer
|
1U54CA233223-01
|
$6,353,982
|
|
MITSIADES, NICHOLAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
$4,733
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
$4,755
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
$4,890
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
$10,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$130,125
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-04
|
$379,294
|
$379,294
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer
|
1U01DE028233-01
|
$536,395
|
|
SIKORA, ANDREW
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A New Target for Chromatin Remodeler Defects in Cancer
|
1R35CA231993-01
|
$594,375
|
|
WALKER, CHERYL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Cancer Genetics Professional Education in a Global Community of Practice
|
2R25CA171998-06
|
$280,269
|
|
BLAZER, KATHLEEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Yes 2 Success
|
1R25CA233431-01
|
$485,999
|
|
KITTLES, RICK
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Targeted activation of autoimmune checkpoints in B cell malignancies
|
7R01CA157644-08
|
$410,875
|
$410,875
|
M?SCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Metabolic basis of B cell lineage leukemia relapse
|
7R35CA197628-02
|
$1,036,898
|
$518,449
|
M?SCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Pharmacological modulation of epigenetic changes in AML
|
5R01CA102031-12
|
$342,107
|
$171,054
|
MARCUCCI, GUIDO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
$3,665
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
$6,250
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$122,334
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Mentored Clinical Scientist Research Career Development Award (Parent K08)
|
1K08CA234394-01
|
$249,042
|
|
SLAVIN, THOMAS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Refinement of CAR-T-Cell therapy targeting glioblastomas
|
1F99CA234923-01
|
$30,024
|
|
WANG, DONGRUI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Role of Vitamin B5 and Coenzyme A Metabolism in PI3K Driven Tumorigenesis
|
4R00CA194314-03
|
$249,000
|
|
DIBBLE, CHRISTIAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Regulatory role of long noncoding RNAs in normal and cancer cells
|
5R50CA211304-02
|
$261,280
|
|
EBRALIDZE, ALEXANDER
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Biomedical Engineering Society Annual Meeting
|
1R13EB026960-01
|
$5,000
|
|
SETTON, LORI
|
BIOMEDICAL ENGINEERING SOCIETY
|
|
|
Cohesin Mutations in Acute Myelogenous Leukemia
|
1R01CA204231-01A1
|
$391,588
|
$195,794
|
RAO, SRIDHAR
|
BLOODCENTER OF WISCONSIN, INC.
|
|
|
Detection of Methylation and Translocation Events by Novel Genomic Technologies
|
3R43CA214386-01S1
|
$50,000
|
|
PEYTAVI, REGIS
|
BLUENOVO BIOSYSTEMS, INC.
|
|
|
Mechanisms of tumorigenesis in Brg1 mutant lung cancer
|
1R01CA216188-01A1
|
$683,713
|
|
KIM, CARLA
|
BOSTON CHILDREN'S HOSPITAL
|
|
|
Development of novel selective Rac inhibitors for refractory leukemias
|
5R01CA202756-02
|
$603,034
|
$603,034
|
WILLIAMS, DAVID
|
BOSTON CHILDREN'S HOSPITAL
|
|
|
Cancer Biology in the Zebrafish
|
2R01CA103846-16A1
|
$420,375
|
|
ZON, LEONARD
|
BOSTON CHILDREN'S HOSPITAL
|
|
|
Non-canonical Notch1 regulation of proliferation and adherens junctions in breast cancer
|
1K99CA226366-01A1
|
$161,676
|
|
KUTYS, MATTHEW
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
|
The MC1R protein palmitoylation in melanoma development
|
1R01CA224432-01A1
|
$386,267
|
|
CUI, RUTAO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
|
1R01CA222170-01A1
|
$559,846
|
|
DENIS, GERALD
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules
|
5R01CA210360-03
|
$621,526
|
|
LENBURG, MARC
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Total relevant funding to Childhood Leukemia for this search: $62,906,339
|
